// App-Quantinova.ai

: Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study

Researchers

Presenter

  • Namhee Kwon

Principal Investigators

  • Kim Gemzoe

  • Sally Worsley

  • Necdet Gunsoy

  • Sandra Joksaite

  • Melissa Van Dyke

  • Carys Bettinson

  • Frank Albers

Medical Centers

  • Global Respiratory Franchise, GSK, Brentford, Middlesex, United Kingdom,

  • Real World Study Delivery, GSK, Stockley Park, Uxbridge, Middlesex, United Kingdom

  • Value Evidence and Outcomes, GSK, Stockley Park, Uxbridge, Middlesex, United Kingdom

  • Real World Evidence & Epidemiology, GSK, Upper Providence, PA, United States,

  • Respiratory Medical Franchise, GSK, Research Triangle Park, NC, United States,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved